tiprankstipranks
Trending News
More News >
ExpreS2ion Biotech Holding AB (SE:EXPRS2)
:EXPRS2
Sweden Market

ExpreS2ion Biotech Holding AB (EXPRS2) Income Statement

Compare
0 Followers

ExpreS2ion Biotech Holding AB Income Statement

Last quarter (Q4 2025), ExpreS2ion Biotech Holding AB's total revenue was kr435.00K, a decrease of -27.38% from the same quarter last year. In Q4, ExpreS2ion Biotech Holding AB's net income was kr-8.18M. See ExpreS2ion Biotech Holding AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 3.66Mkr 3.01Mkr 7.05Mkr 5.09Mkr 12.23M
Gross Profit
kr -42.84Mkr -2.67Mkr 3.40Mkr 5.00Kkr 4.72M
Operating Expenses
kr 9.98Mkr 69.84Mkr 111.12Mkr 127.61Mkr 53.12M
Depreciation and Amortization
kr 1.47Mkr 1.64Mkr 1.60Mkr 1.22Mkr 1.81M
EBITDA
kr -51.35Mkr -64.34Mkr -102.45Mkr -124.49Mkr -46.38M
Operating Income
kr -52.82Mkr -67.69Mkr -105.97Mkr -127.61Mkr -48.40M
Other Income/Expenses
kr 8.64Mkr 23.13Mkr 6.00Mkr 1.02Mkr 880.00K
Pretax Income
kr -44.18Mkr -44.56Mkr -99.97Mkr -126.58Mkr -47.52M
Net Income
kr -38.09Mkr -36.04Mkr -91.40Mkr -118.61Mkr -43.92M
Per Share Metrics
Basic EPS
kr -13.39kr -21.31kr -79.20kr -125.60kr -54.40
Diluted EPS
kr -13.39kr -14.02kr -79.20kr -125.60kr -54.40
Weighted Average Shares Outstanding
2.84M 1.69M 1.15M 943.47K 806.21K
Weighted Average Shares Outstanding (Diluted)
2.84M 2.60M 1.15M 943.47K 806.21K
Currency in SEK

ExpreS2ion Biotech Holding AB Earnings and Revenue History